← FDA Drug Approvals (Drugs@FDA)

LARIN 1.5/30

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2014-03-20

Drug application

FDA Application #

ANDA202996

Application type

Abbreviated New Drug Application (Generic)

Brand name

LARIN 1.5/30

Generic name

NORETHINDRONE ACETATE/ETHINYL ESTRADIOL

Active ingredients

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Dosage form

TABLET

Route

ORAL-21

Marketing status

Prescription

Sponsor

NOVAST LABS

Manufacturer

Northstar Rx LLC

First approval

2014-03-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown